AMEX · KAPA
Healthcare · Biotechnology
$0.36
Up+$0.01 (+1.52%)
Updated Aug 14, 2026, 2:09 AM
SID Score
3.2/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
KAPA does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning KAPA.
KAPA research
Company profile and research snapshot.
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. It is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Nov 19, 2025 | D. Boral Capital | Buy | — |
| Nov 4, 2025 | D. Boral Capital | Buy | — |
| Oct 20, 2025 | D. Boral Capital | Buy | — |
| Oct 7, 2025 | D. Boral Capital | Buy | — |
| Sep 19, 2025 | D. Boral Capital | Buy | — |
No generated briefing is available yet.
Benzinga · Jul 22, 2026
Gainers Zhengye Biotechnology (NASDAQ:ZYBT) shares moved upwards by 24.0% to $1.71 during Wednesday's after-market session. The market value of their outstanding shares is at $135.0 million. Medpace Holdings
Benzinga · Jul 22, 2026
Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on overcoming cancer drug resistance, today announced a strategic collaboration with Bayer to evaluate Kairos Pharma’s lead
Benzinga · Jul 16, 2026
Kairos Pharma shares surged 22.64% after hours following positive interim safety data from its lead cancer drug candidate ENV-105.
Benzinga · Jul 15, 2026
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning KAPA.
